Propiedad y actividad de insiders de Ensysce Biosciences, Inc. (ENSC): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.45 |
| Capitalización | $7M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-07 | GOWER BOB G | P-Purchase | 400,000 | $198K |
| 2026-04-23 | GOWER BOB G | P-Purchase | 508,614 | $246K |
| 2026-04-23 | GOWER BOB G | C-Conversion | 254,307 | $123K |
| 2026-08-05 | Morrison James William | 154,821,000 | ||
| 2023-03-02 | GOWER BOB G | P-Purchase | 90,287 | $44K |
| 2023-03-01 | GOWER BOB G | P-Purchase | 270,000 | $129K |
| 2023-02-28 | GOWER BOB G | P-Purchase | 109,300 | $53K |
| 2022-12-09 | GOWER BOB G | P-Purchase | 357,143 | $500K |
| 2022-12-09 | GOWER BOB G | A-Award | 714,286 | $1.0M |
| 2022-06-23 | Chang William H | A-Award | 15,000 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $2.1M | $1.7M | $341536 | $194214 | $12.3M | $3.1M | $1.1M | $3.5M | $4.3M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | $170535 | $173552 | 0 | $441721 | $276821 | $97561 | $124115 | $420345 |
| Inventario | 0 | 0 | 0 | 0 | -$441721 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $2.3M | $1.9M | $618590 | $347876 | $15.7M | $5.3M | $2.3M | $5.3M | $7.2M |
| Inmovilizado Material | 0 | 0 | $351 | $151 | $24.72B | 0 | 0 | 0 | $124129 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $202.4M | $204.8M | $623941 | $351807 | $16.4M | $5.9M | $2.7M | $5.6M | $7.5M |
| Cuentas por Pagar | 0 | 0 | $540778 | $1.7M | $301104 | $2.9M | $1.9M | $1.4M | $3.3M |
| Deuda a Corto | 0 | 0 | $2.6M | $4.2M | $12.7M | $4.3M | $854697 | $301660 | $306708 |
| Pasivos Corrientes | $156239 | $437886 | $7.3M | $7.0M | $16.5M | $9.5M | $3.3M | $2.2M | $4.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $4.4M | $140148 | 0 | 0 | 0 |
| Pasivos Totales | $7.2M | $7.4M | $7.3M | $7.0M | $24.6M | $9.9M | $3.4M | $2.2M | $4.6M |
| Reservas | -$31193 | $2.1M | -$56.0M | -$56.0M | -$85.8M | -$110.9M | -$121.6M | -$129.5M | -$139.7M |
| Patrimonio Neto | $195.3M | $197.4M | -$6.7M | -$6.4M | -$7.9M | -$3.7M | -$322858 | $3.7M | $3.2M |
| Deuda Total | 0 | 0 | $2.6M | $4.3M | $17.2M | $4.4M | $854697 | $301660 | $306708 |
| Deuda Neta | -$2.1M | -$1.7M | $2.3M | $4.1M | $4.9M | $1.3M | -$268907 | -$3.2M | -$4.0M |
| Capital Circulante | $2.2M | $1.5M | -$6.7M | -$6.7M | -$819073 | -$4.2M | -$1.0M | $3.1M | $2.7M |
Salud financiera
| Deuda / Patrimonio | -0.25 |
| Ratio corriente | 0.70 |
| Piotroski F-Score | 0 |
| Altman Z-Score | -29.36 |
Rentabilidad
| Rentabilidad sobre capital | -316.63% |
| Rentabilidad sobre capital invertido | -320.89% |
| Rentabilidad sobre activos | -136.54% |
| Margen bruto | 100.00% |
| Margen operativo | -1087.47% |
| Margen neto | -1084.23% |
Empresas relacionadas: AIM · CANF · KALA · KZIA · OGEN · QLGN · SNGX
Explorar sector: Healthcare · Biotechnology
Más secciones de ENSC: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones